Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrea L. Adams"'
Autor:
Dustin T. Atchley, Traci M. Tanaka Hall, Xiaojiang Xu, Jason Williams, Bart T. Phillips, Andrea L. Adams, Katina L. Johnson, Jian-Liang Li
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Spermatogenesis is a differentiation process that requires dramatic changes to DNA architecture, a process governed in part by Transition Nuclear Proteins 1 and 2 (TNP1 and TNP2). Translation of Tnp1 and Tnp2 mRNAs is temporally disengaged from their
Autor:
Valerie Hudak, Zhiming Zhang, Yuan Zhu, Cheryl A. Mugford, Michael A. Marella, Thomas J. Berrodin, Kern Jeffrey Curtis, William R. Adams, Edward George Melenski, Matthew Yudt, Jeff Cohen, Richard C. Winneker, Ov D. Slayden, Andrea L. Adams, Andrew Fensome, Jay E. Wrobel, Puwen Zhang, Casey C. McComas, Arthur Illenberger, Christine Huselton
Publikováno v:
Journal of medicinal chemistry. 51(6)
We have continued to explore the 3,3-dialkyl-5-aryloxindole series of progesterone receptor (PR) modulators looking for new agents to be used in female healthcare: contraception, fibroids, endometriosis, and certain breast cancers. Previously we repo
Autor:
Andrea L. Adams, Matthew P. Boente, Michael Millenson, Barbara B. Rogers, Norman G. Rosenblum, Kristin Padavic-Shallers, James M. Gallo, Robert F. Ozols, Russell J. Schilder, Louis M. Weiner, Andre Rogatko, Suzanne Ciccotto, Michael A. Bookman
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19(4)
PURPOSE: To determine the safety and feasibility of delivering multiple cycles of front-line high-dose carboplatin, paclitaxel, and topotecan with peripheral-blood stem-cell (PBSC) support. PATIENTS AND METHODS: Patients were required to have a malig
Autor:
Christine E. Szarka, Deborah Kilpatrick, Andrea L. Adams, James M. Gallo, Samuel Litwin, Diane Brady, Neal J. Meropol, Paul F. Engstrom, Nancy L. Lewis, Louis M. Weiner, Richard Scher
Publikováno v:
Cancer chemotherapy and pharmacology. 50(4)
Purpose. To determine the maximum tolerated dose (MTD) of raltitrexed when given with irinotecan and to evaluate the pharmacokinetics of these two agents when given in combination. Methods. Patients with advanced solid tumors received irinotecan intr
Autor:
Andrew Fensome, William R. Adams, Andrea L. Adams, Tom J. Berrodin, Jeff Cohen, Christine Huselton, Arthur Illenberger, Jeffrey C. Kern, Valerie A. Hudak, Michael A. Marella, Edward G. Melenski, Casey C. McComas, Cheryl A. Mugford, Ov D. Slayden, Matthew Yudt, Zhiming Zhang, Puwen Zhang, Yuan Zhu, Richard C. Winneker, Jay E. Wrobel
Publikováno v:
Journal of Medicinal Chemistry; Feb2008, Vol. 51 Issue 6, p1861-1873, 13p